T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLPX
2976
DELISTED
Olaplex Holdings
OLPX
| $217K | ﹤0.01% |
105,605
+7,084
| +7% | +$14.4K |
|
2977
Lands' End
LE
$313M
| $216K | ﹤0.01% |
20,605
+1,883
| +10% | +$21.6K |
|
2978
DiaMedica Therapeutics
DMAC
$355M
| $215K | ﹤0.01% |
30,492
+7,322
| +32% | +$45K |
|
|
FWDI
2979
Forward Industries Inc
FWDI
$484M
| $215K | ﹤0.01% |
+50,913
| New | +$227K |
|
2980
MGP Ingredients
MGPI
$323M
| $214K | ﹤0.01% |
+12,180
| New | +$222K |
|
|
CBK
2981
Commercial Bancgroup
CBK
$462M
| $214K | ﹤0.01% |
+6,604
| New | +$193K |
|
|
ALMU
2982
Aeluma Inc
ALMU
$243M
| $213K | ﹤0.01% |
+9,633
| New | +$206K |
|
2983
Bally's
BALY
$448M
| $211K | ﹤0.01% |
15,374
+2,788
| +22% | +$35.6K |
|
|
EU
2984
enCore Energy
EU
$235M
| $210K | ﹤0.01% |
160,036
+34,123
| +27% | +$57.4K |
|
2985
NRC Health Common Stock
NRC
$463M
| $210K | ﹤0.01% |
+9,708
| New | +$180K |
|
2986
Stem
STEM
$51.7M
| $209K | ﹤0.01% |
26,655
+12,741
| +92% | +$118K |
|
2987
Tencent Music
TME
$12.9B
| $208K | ﹤0.01% |
24,903
| – | – |
|
2988
Electromed
ELMD
$226M
| $207K | ﹤0.01% |
+4,878
| New | +$156K |
|
2989
T. Rowe Price Ultra Short-Term Bond ETF
TBUX
$1.56B
| – | – |
0
| – | – |
|
2990
American Coastal Insurance
ACIC
$439M
| $206K | ﹤0.01% |
18,537
+1,134
| +7% | +$12.5K |
|
2991
Biglari Holdings Class B
BH
$1.16B
| $206K | ﹤0.01% |
+482
| New | +$150K |
|
2992
Compañía de Minas Buenaventura
BVN
$8.99B
| $206K | ﹤0.01% |
7,000
| – | – |
|
2993
Eve Holding
EVEX
$749M
| $205K | ﹤0.01% |
81,627
+15,990
| +24% | +$46.1K |
|
2994
Inhibikase Therapeutics
IKT
$336M
| $203K | ﹤0.01% |
99,632
+48,758
| +96% | +$87.3K |
|
2995
Xponential Fitness
XPOF
$170M
| $203K | ﹤0.01% |
29,290
+11,332
| +63% | +$71.7K |
|
2996
Abeona Therapeutics
ABEO
$331M
| $202K | ﹤0.01% |
32,591
+1,586
| +5% | +$8.71K |
|
|
LMRI
2997
Lumexa Imaging Holdings
LMRI
$1.08B
| $202K | ﹤0.01% |
17,874
| – | – |
|
2998
Ribbon Communications
RBBN
$352M
| $201K | ﹤0.01% |
85,744
+15,922
| +23% | +$42K |
|
2999
Zentalis Pharmaceuticals
ZNTL
$360M
| $200K | ﹤0.01% |
+41,049
| New | +$164K |
|
|
WBTN
3000
WEBTOON Entertainment Inc
WBTN
$1.37B
| $200K | ﹤0.01% |
17,480
+4,529
| +35% | +$53.6K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.